Unlock 30% off global market reports with code ONLINE30 – get insights on tariff changes, macro trends, and global economic shifts.
What are the growth projections for the toxicology drug screening market from 2024 to 2029?
The toxicology drug screening market size has grown strongly in recent years. It will grow from $19.56 billion in 2024 to $21.44 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to rising drug abuse cases, implementation of workplace drug testing policies, increasing adoption of toxicology screening in sports, expansion of forensic toxicology services, and growth in criminal investigations requiring toxicology reports.
The toxicology drug screening market size is expected to see strong growth in the next few years. It will grow to $30.67 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to growing demand for personalized medicine, increasing regulatory focus on drug safety, rising use of cannabis and synthetic drugs, expansion of healthcare infrastructure in emerging markets, and rising incidence of substance abuse. Major trends in the forecast period include advancement in high-throughput screening technologies, advanced integration of AI in toxicology analysis, development of point-of-care toxicology tests, innovation in biomarker-based screening methods, and advancement in automation and robotics for drug screening.
Download Your Free Sample PDF:
What strategic initiatives by market players are driving toxicology drug screening industry growth?
The rising prevalence of drug abuse is expected to propel the growth of the toxicology drug screening market going forward. Drug abuse is the harmful or excessive use of drugs for non-medical purposes that negatively impacts a person’s health and life. The prevalence of drug abuse is rising due to increased stress and mental health challenges, which lead many individuals to misuse substances as a way to cope. Toxicology drug screening is useful for drug abuse because it helps detect the presence of drugs or their metabolites in a person’s body, enabling early identification, diagnosis, and monitoring of substance misuse or overdose. For instance, in August 2024, according to the National Records of Scotland (NRS), a Scotland-based government department, Scotland recorded 1,172 drug misuse deaths in 2023, marking a 12% rise (121 additional deaths) compared to 2022. Therefore, the rising prevalence of drug abuse is driving the growth toxicology drug screening market.
What emerging segments are shaping the future landscape of the toxicology drug screening industry?
The toxicology drug screening market covered in this report is segmented –
1) By Type: Monitoring And Logging, Security, Storage And Continuous Integration Or Continuous Deployment, Management And Orchestration, Networking And Data Management Services, Other Types
2) By Test Type: Acute Systemic Toxicity, Dermal Toxicity, Carcinogenicity, Ocular Toxicity, Genotoxicity, Neurotoxicity, Organ-Specific Toxicity
3) By Technology Type: High-Throughput Screening, Genomics, Transcriptomics, Toxicogenomics, Molecular Screening
4) By Application: Immunotoxicity, Systemictoxicity, Developmental And Reproductive Toxicity (DART), Endocrine Disruption, Other Applications
5) By End Users: Hospitals, Clinics, Contract Research Organizations (CROs), Pharmaceutical Companies, Workplace Testing Facilities
Subsegments:
1) By Monitoring And Logging: Real-Time Drug Monitoring Systems, Bioanalytical Instrumentation Logs, Toxicity Alert Notification Systems, Compliance And Audit Trail Monitoring
2) By Security: Data Encryption Solutions For Lab Reports, Access Control Systems For Toxicology Data, Secure Sample Tracking Systems, HIPAA Or GDPR-Compliant Drug Testing Platforms
3) By Storage And Continuous Integration Or Continuous Deployment: Cloud-Based Sample Data Storage Solutions, Automated Toxicology Report Generation Pipelines, LIMS (Laboratory Information Management Systems) Integration Tools, Version Control For Test Protocols And Databases
4) By Management And Orchestration: Workflow Automation Tools For Toxicology Labs, Centralized Dashboard For Drug Screening Management, Multi-Site Test Scheduling And Coordination Platforms, Vendor Management Systems For Lab Supplies
5) By Networking And Data Management Services: Interoperability Platforms For Healthcare Data Exchange, Toxicology Data Integration Services With EHR/EMR Systems, Remote Access For Toxicology Results And Analysis, Data Warehousing For Toxicology And Screening Records
6) By Other Types: AI-Powered Predictive Toxicology Platforms, Mobile Drug Screening Applications, Blockchain-Based Chain Of Custody Solutions, Voice And Image Recognition Tools In Toxicology
View The Full Market Report:
Which major trends are influencing the growth of the toxicology drug screening industry?
Major companies operating in the toxicology drug screening market are focusing on introducing innovative solutions, such as forensic toxicology screening, to enhance the accuracy and speed of substance detection in clinical, forensic, and workplace settings. Forensic toxicology screening is the analysis of biological samples to detect and identify drugs, poisons, or toxins involved in crimes, accidents, or deaths for legal investigation purposes. For instance, in June 2022, Thermo Fisher Scientific Inc., a US-based biotechnology and life sciences company, launched the ToxSpec Analyzer, a comprehensive LC-MS (liquid chromatography-mass spectrometry) solution tailored for clinical and forensic toxicology screening. This system integrates hardware, software, and validated methodologies to automate and streamline the screening of drug analytes, making it accessible even for laboratories new to LC-MS/MS technology. The ToxSpec Analyzer enhances workflow efficiency, increases identification confidence, and offers flexibility to add new compounds as needed.
How are key players in the toxicology drug screening market strengthening their market position?
Major companies operating in the toxicology drug screening market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, BD Bioscience, Quest Diagnostics, ICON plc, Agilent Technologies Inc., Eurofins Scientific SE, Wuxi AppTec, Charles River Laboratories International Inc., Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Evotec AG, Promega Corporation, The Jackson Laboratory, Clinical Reference Laboratory Inc., Enzo Life Sciences Inc., Covance Inc., Randox Toxicology, Alere Inc.
Which geographic areas are contributing significantly to the growth of the toxicology drug screening sector?
North America was the largest region in the toxicology drug screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the toxicology drug screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Toxicology Drug Screening Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
Need Customized Data On Toxicology Drug Screening Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you're entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Comments
Post a Comment